Skip to content

Clinical trials

Thalassemia trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Country / region: Israel Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20083
20093
20112
20131
20151
20181
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status2
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
HaEmek Medical Center, Israel11
Novartis Pharmaceuticals2
Agios Pharmaceuticals, Inc.1
Cyprus Institute of Neurology and Genetics1
Sheba Medical Center1
Terumo BCTbio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia17
Anemia, Sickle Cell9
Iron Overload3
Infections2
beta-Thalassemia2
Anemia1
Anemia, Diamond-Blackfan1
Anemia, Hemolytic1
Anorexia1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.